(Q41861535)

English

Inhibition of allergen-induced airway obstruction and leukotriene generation in atopic asthmatic subjects by the leukotriene biosynthesis inhibitor BAYx 1005

scientific article published on April 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Inhibition of allergen-induced airway obstruction and leukotriene generation in atopic asthmatic subjects by the leukotriene biosynthesis inhibitor BAYx 1005 (English)

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

0 references

author name string

Dahlén B

1

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Kumlin M

2

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Ihre E

3

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Zetterström O

4

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Dahlén SE

5

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

language of work or name

0 references

publication date

1 April 1997

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

52

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

4

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

342-347

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1758539

5 June 2018

Mode of action of the new selective leukotriene synthesis inhibitor BAY X 1005 ((R)-2-[4-(quinolin-2-yl-methoxy)phenyl]-2-cyclopentyl acetic acid) and structurally related compounds

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1758539

5 June 2018

Effect of the 5-lipoxygenase inhibitor ZD2138 on allergen-induced early and late asthmatic responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1758539

5 June 2018

Leukotriene receptor antagonists and biosynthesis inhibitors: potential breakthrough in asthma therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1758539

5 June 2018

Methacholine bronchial challenge using a dosimeter with controlled tidal breathing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1758539

5 June 2018

Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1758539

5 June 2018

Allergen-stimulated release of thromboxane A2 and leukotriene E4 in humans. Effect of indomethacin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1758539

5 June 2018

Characteristics of formation and further metabolism of leukotrienes in the chopped human lung

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1758539

5 June 2018

Prevention of exercise-induced bronchoconstriction by a new leukotriene antagonist (SK&F 104353). A double-blind study versus disodium cromoglycate and placebo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1758539

5 June 2018

Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1758539

5 June 2018

Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1758539

5 June 2018

The two-period cross-over clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1758539

5 June 2018

The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1758539

18 August 2018

(R)-2-[4-(quinolin-2-yl-methoxy)phenyl]-2-cyclopentyl] acetic acid (BAY x1005), a potent leukotriene synthesis inhibitor: effects on anti-IgE challenge in human airways

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1758539

2 December 2018

Urinary leukotriene E4 levels during early and late asthmatic responses†

1 reference

https://pubmed.ncbi.nlm.nih.gov/9196517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/9196517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The potent and selective sulfidopeptide leukotriene antagonist, SK&F 104353, inhibits aspirin-induced asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9196517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urinary Excretion of Leukotriene E4and 11-dehydro-Thromboxane B2in Response to Bronchial Provocations with Allergen, Aspirin, Leukotriene D4, and Histamine in Asthmatics

1 reference

https://pubmed.ncbi.nlm.nih.gov/9196517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral leukotriene inhibitor (MK-886) blocks allergen-induced airway responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/9196517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of antigen-induced contraction of guinea-pig airways by a leukotriene synthesis inhibitor, BAY x1005

1 reference

https://pubmed.ncbi.nlm.nih.gov/9196517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interactions between leukotrienes and histamine in the anaphylactic contraction of guinea pig lung parenchyma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9196517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validation and application of a new simple strategy for measurements of urinary leukotriene E4 in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/9196517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist

1 reference

https://pubmed.ncbi.nlm.nih.gov/9196517

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/THX.52.4.342

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41861535&oldid=1549314271"